North America Animal Model Market Forecast 2027 By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Application (Research & Development {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}, Production and Quality Control, Academics, Preclinical Applications {Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Obesity, NAFLD/NASH, Renal Disease, Diabetic Eye Disease, Fibrosis, Microbiome}), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-government}, Academic and Research Institutes, Contract Research Organizations (CRO)), Research Report, Regional Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
Published Date: June 2021   |   Report ID: GR1851   |   Delivery: PDF  Request Free Sample

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    North America animal model industry 360⁰ synopsis, 2016 - 2027

2.1.1    Country trends

2.1.2    Animal type trends

2.1.3    Technology trends

2.1.4    Application trends

2.1.5    Use trends

2.1.6    End-use trends

Chapter 3   North America Animal Model Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 - 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing number of pharmaceutical research and development activities

3.3.1.2    Large number of applications in healthcare domain

3.3.1.3    Physiological similarities between human and animal

3.3.1.4    Emergence of CRISPR as a powerful tool in the field of biomedical research

3.3.1.5    Growing consumption of personalized medicine driving the demand for humanized mice models

3.3.2    Industry pitfalls & challenges

3.3.2.1    Expensive process

3.3.2.2    Strict regulations and guidelines

3.3.2.3    Growing opposition on animal testing by several organizations

3.4    Analysis of COVID-19 impact on the industry

3.5    Porter’s analysis

3.6    Competitive landscape, 2020

3.7    PEST analysis

Chapter 4   North America Animal Model Market, By Animal Type

4.1    Market trends

4.2    Mice

4.2.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.2.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.3    Rats

4.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.3.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.4    Fish

4.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.4.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.5    Birds

4.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.5.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.6    Cattles

4.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.6.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.7    Pigs

4.7.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.7.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.8    Amphibians

4.8.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.8.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.9    Guinea Pigs

4.9.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.9.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.10    Dogs

4.10.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.10.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.11    Cats

4.11.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.11.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.12    Rabbits

4.12.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.12.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.13    Monkeys

4.13.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.13.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.14    Sheep

4.14.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.14.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.15    Hamsters

4.15.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.15.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

4.16    Others

4.16.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

4.16.2    Market estimate and forecast, by country, 2016 – 2027 (Units)

Chapter 5   North America Animal Model Market, By Technology

5.1    Market trends

5.2    CRISPR

5.2.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

5.3    Microinjection

5.3.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

5.4    Embryonic Stem Cell Injection

5.4.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

5.5    Nuclear Transfer

5.5.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

5.6    Others

5.6.1    Market estimate and forecast, by country, 2016 – 2027 (USD Million)

Chapter 6   North America Animal Model Market, By Application

6.1    Market trends

6.2    Research & Development

6.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.2    Infectious Disease

6.2.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.3    Immunological Disease

6.2.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.4    Cancer

6.2.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.5    Cardiovascular Disease

6.2.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.6    Diabetes

6.2.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.7    Genetic Disease

6.2.7.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.8    Neurological Disease

6.2.8.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.9    Obesity

6.2.9.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.10    NAFLD/NASH

6.2.10.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.11    Renal Disease

6.2.11.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.12    Diabetic Eye Disease

6.2.12.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.13    Fibrosis

6.2.13.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.14    Microbiome

6.2.14.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.2.15    Others

6.2.15.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.3    Production & Quality Control

6.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.4    Academics

6.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5    Preclinical Applications

6.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.2    Infectious Disease

6.5.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.3    Immunological Disease

6.5.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.4    Cancer

6.5.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.5    Cardiovascular Disease

6.5.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.6    Diabetes

6.5.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.7    Genetic Disease

6.5.7.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.8    Neurological Disease

6.5.8.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.9    Obesity

6.5.9.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.10    NAFLD/NASH

6.5.10.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.11    Renal Disease

6.5.11.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.12    Diabetic Eye Disease

6.5.12.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.13    Fibrosis

6.5.13.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.14    Microbiome

6.5.14.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.5.15    Others

6.5.15.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

6.6    Others

6.6.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

Chapter 7   North America Animal Model Market, By Use

7.1    Market trends

7.2    Human

7.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

7.3    Veterinary

7.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

Chapter 8   North America Animal Model Market, By End-use

8.1    Market trends

8.2    Companies

8.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.2.2    Pharmaceutical

8.2.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.2.3    Biotechnology

8.2.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.2.4    Cosmetics

8.2.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.2.5    Others

8.2.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.3    Organizations

8.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.3.2    Government

8.3.2.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.3.3    Non-government

8.3.3.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.4    Academic & Research Institutes

8.4.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

8.5    Contract Research Organizations

8.5.1    Market estimate and forecast, by country, 2016 - 2027 (USD Million)

Chapter 9   North America Animal Model Market, By Country

9.1    Market trends

9.2    U.S.

9.2.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.2.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.2.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.2.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.2.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.2.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.2.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.2.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.2.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.2.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

9.3    Canada

9.3.1    Market estimate and forecast, by animal type, 2016 – 2027 (USD Million)

9.3.2    Market estimate and forecast, by animal type, 2016 – 2027 (Units)

9.3.3    Market estimate and forecast, by technology, 2016 – 2027 (USD Million)

9.3.4    Market estimate and forecast, by application, 2016 – 2027 (USD Million)

9.3.4.1    Market estimate and forecast, by research & development, 2016 – 2027 (USD Million)

9.3.4.2    Market estimate and forecast, by preclinical applications, 2016 – 2027 (USD Million)

9.3.5    Market estimate and forecast, by use, 2016 – 2027 (USD Million)

9.3.6    Market estimate and forecast, by end-use, 2016 – 2027 (USD Million)

9.3.6.1    Market estimate and forecast, by companies, 2016 – 2027 (USD Million)

9.3.6.2    Market estimate and forecast, by organizations, 2016 – 2027 (USD Million)

Chapter 10   Company Profiles

10.1    Charles River

10.1.1    Business overview

10.1.2    Financial data

10.1.3    Product landscape

10.1.4    Strategic outlook

10.1.5    SWOT analysis

10.2    Envigo

10.2.1    Business overview

10.2.2    Financial data

10.2.3    Product landscape

10.2.4    Strategic outlook

10.2.5    SWOT analysis

10.3    genOway

10.3.1    Business overview

10.3.2    Financial data

10.3.3    Product landscape

10.3.4    Strategic outlook

10.3.5    SWOT analysis

10.4    Harbour BioMed

10.4.1    Business overview

10.4.2    Financial data

10.4.3    Product landscape

10.4.4    Strategic outlook

10.4.5    SWOT analysis

10.5    Janvier Labs

10.5.1    Business overview

10.5.2    Financial data

10.5.3    Product landscape

10.5.4    Strategic outlook

10.5.5    SWOT analysis

10.6    PharmaLegacy

10.6.1    Business overview

10.6.2    Financial data

10.6.3    Product landscape

10.6.4    Strategic outlook

10.6.5    SWOT analysis

10.7    Taconic Biosciences Inc.

10.7.1    Business overview

10.7.2    Financial data

10.7.3    Product landscape

10.7.4    Strategic outlook

10.7.5    SWOT analysis

10.8    The Jackson Laboratory

10.8.1    Business overview

10.8.2    Financial data

10.8.3    Product landscape

10.8.4    Strategic outlook

10.8.5    SWOT analysis

10.9    TRANS GENIC INC, Ltd.

10.9.1    Business overview

10.9.2    Financial data

10.9.3    Product landscape

10.9.4    Strategic outlook